dihexa pnb-0408 c-met hgfr activator Buy – CAS 1401708-83-5 Negative control of the HGF/c-MET
Negative control of the HGF c MET pathway by TGF : a new look at the regulation of stemness in glioblastoma Cell Death & Disease HGF c MET pathway in cancer: from molecular characterization to clinical evidence Oncogene Dihexa Biorbyt Pancreatic Cancer Treatment Targeting the HGF c MET Pathway: The MEK Inhibitor Trametinib
Pay in 4 interest-free payments of $6.73 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7



